The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Symptom Severity Decreases in Patients with Psoriatic Arthritis who Undergo Weight-Loss Surgery
A retrospective analysis of patients who underwent bariatric surgery suggests that significant weight loss significantly lessens the symptoms of psoriasis and psoriatic arthritis.
Post-Ablation Recurrence Risk Increases with BMI in Patients with Atrial Fibrillation
Analyses of patient records indicate that obesity increases the risk of recurrence among patients who undergo ablation for atrial fibrillation but suggest that sustained weight loss can reduce the risk.
Pancreatic Volume Predicts Postoperative Risk of Exocrine Pancreatic Insufficiency
New research into the relationship between partial pancreatectomy and the subsequent incidence of exocrine pancreatic insufficiency finds a strong positive correlation between the volume of tissue removed and subsequent complications.
Study Identifies Characteristics of Pain Improvement for Bariatric Surgery Patients
In preliminary results presented at ObesityWeek, University of Pittsburgh researchers revealed that 3 years after bariatric surgery, the majority of patients experience an improvement in pain and walking ability.
Updated Malignant Hyperthermia Guidelines
November 4th 2015Malignant hyperthermia is a potentially fatal disorder usually associated with administration of certain general anesthetics and/or succinylcholine. Until 30 years ago, its etiology was unknown. Then, researchers found that people who carry an autosomal dominant calcium channel mutation are at elevated susceptibility.
Type 2 Diabetes ELIXA Trial Update on CV Risk, Stroke, and Mortality
October 30th 2015The much buzzed about Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial has been tracking the medication in patients with type 2 diabetes. An update on the outcomes was provided at the 10th Annual Cardiometabolic Health Congress (CMHC 2015) in Boston, Massachusetts.
Researchers to Study Biomarkers for Early Detection of Diabetic Kidney Disease
October 24th 2015As part of a multi-institutional effort, researchers in the fields of proteomics, lipidomics, and metabolomics will collaborate to discover more effective ways of predicting which patients with type 1 diabetes are at greater risk for developing kidney disease.
Reversing Choline-Depletion in Children with Cystic Fibrosis and Exocrine Pancreatic Insufficiency
A clinical trial with a choline-rich structured lipid found that daily intake can significantly reduce choline depletion in cystic fibrosis patients with exocrine pancreatic insufficiency.